Compare Corning Incorporated (GLW) vs Natera Inc. Common Stock (NTRA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Corning Incorporated vs Natera Inc. Common Stock — how do they compare? Corning Incorporated trades at $135.17 (market cap $121.36B), while Natera Inc. Common Stock trades at $392.78 (market cap $57.03B). The key difference: Corning Incorporated is far larger — about 2.1× Natera Inc. Common Stock's market cap, and Corning Incorporated pays a 0.79% dividend while Natera Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Corning Incorporated for 36 Days and Natera Inc. Common Stock for 0 Days on average.
| GLW | NTRA | |
|---|---|---|
Market Cap | $121.36B | $57.03B |
Volume | 7,874,233 | 1,131,157 |
Sector | Technology | Health |
52-Week High | $255.79 | $425.64 |
52-Week Low | $78.03 | $179.42 |
Typical Hold Time | 36 Days | 0 Days |
Enterprise Value | $128.24B | $56.18B |
Dividend Yield | 0.79% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Corning (GLW) trades at $148.52, up 0.87% with recent earnings beats and a major $3B AT&T fiber deal driving optimism. Technical indicators show bearish momentum with support at $144 and resistance at $153. The company demonstrates strong fundamental improvement with 2025 revenue reaching $15.63B and net income surging to $1.60B, though valuation multiples remain elevated with a P/E of 68.45.
GLW presents growth potential through AI infrastructure demand and fiber expansion, supported by 57% analyst buy ratings and a $171.25 price target. Key risks include patent litigation investigations and high valuation sensitivity to earnings growth. The stock offers 15% upside to consensus target but requires monitoring of legal developments and margin sustainability.
NTRA trades at $395.66, down 0.53% today but remains near recent highs. The stock shows mixed technical signals with neutral momentum indicators. Fundamentally, the company demonstrates strong revenue growth ($2.31B in 2025, projected $2.7B in 2026) but continues to operate at a net loss (-$208M in 2025). Recent positive developments include FDA Breakthrough Device designation for its multi-cancer detection assay and regulatory approval in Japan for Signatera.
NTRA presents a growth story with significant analyst support (89% buy ratings) but carries execution risks. The stock trades at premium valuations (P/S 20.48) while still unprofitable. Key catalysts include clinical trial progress and international expansion, though investors face risks from ongoing losses and competitive pressures in precision medicine.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Corning Incorporated
Corning Inc is a leader in materials science, specializing in the production of glass, ceramics and optical fiber. The firm supplies its products for a wide range of applications, from flat-panel displays in televisions to gasoline particulate filters in automobiles to optical fiber for broadband access, with a leading share in many of its end markets.
Read more on GLW →About Natera Inc. Common Stock
Natera, Inc. develops and provides cell-free DNA-based genetic testing across women's health, oncology, organ health, and rare disease, with flagship products including Panorama for noninvasive prenatal screening and Signatera for cancer recurrence monitoring.
Read more on NTRA →
